PL416716A1 - Szczepy bakteriofagów i ich zastosowania - Google Patents

Szczepy bakteriofagów i ich zastosowania

Info

Publication number
PL416716A1
PL416716A1 PL416716A PL41671616A PL416716A1 PL 416716 A1 PL416716 A1 PL 416716A1 PL 416716 A PL416716 A PL 416716A PL 41671616 A PL41671616 A PL 41671616A PL 416716 A1 PL416716 A1 PL 416716A1
Authority
PL
Poland
Prior art keywords
strain
preparation
bacteriophages
application
subject
Prior art date
Application number
PL416716A
Other languages
English (en)
Inventor
Arkadiusz Wojtasik
Elżbieta Górecka
Ewelina Wójcik
Małgorzata Stańczyk
Joanna Kołsut
Justyna Klimczak
Jarosław Dastych
Andrzej K. Siwicki
Patrycja Schulz
Original Assignee
Proteon Pharmaceuticals Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteon Pharmaceuticals Spółka Akcyjna filed Critical Proteon Pharmaceuticals Spółka Akcyjna
Priority to PL416716A priority Critical patent/PL416716A1/pl
Priority to US16/090,772 priority patent/US11077155B2/en
Priority to CA3019820A priority patent/CA3019820A1/en
Priority to MX2018012099A priority patent/MX2018012099A/es
Priority to CN201780032927.5A priority patent/CN109310721B/zh
Priority to PCT/PL2017/050018 priority patent/WO2017176136A1/en
Priority to EP17779411.2A priority patent/EP3439677A4/en
Publication of PL416716A1 publication Critical patent/PL416716A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10233—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest zastosowanie bakteriofagów do wytwarzania preparatu do zapobiegania lub zwalczania zakażeń zwierząt hodowlanych, zwłaszcza ryb, patogennymi szczepami bakterii wrażliwymi na działanie tych bakteriofagów, przy czym wytwarzany preparat jest przeznaczony do podawania zagrożonym zwierzętom w immersji, korzystnie w odstępach 24 - godzinnych. Ponadto zgłoszenie obejmuje też zastosowanie bakteriofagów do wytwarzania preparatu do stymulowania nieswoistych komórkowych i humoralnych mechanizmów obronnych i odporności przeciwzakaźnej ryb. Przedmiotem zgłoszenia jest także szczep bakteriofaga, wybrany z grupy obejmującej szczepy zdeponowane w Polskiej Kolekcji Mikroorganizmów pod następującymi numerami depozytowymi: F/00096 (szczep 25AhydR2PP), F/00094 (szczep 50AhydR13PP), F/00098 (szczep 22PfluR64PP), F/00099 (szczep 67PfluR64PP), F/00100 (szczep 71PfluR64PP), F/00095 (szczep 98PfluR60PP) oraz F/00101 (szczep 60AhydR15PP).
PL416716A 2016-04-03 2016-04-03 Szczepy bakteriofagów i ich zastosowania PL416716A1 (pl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PL416716A PL416716A1 (pl) 2016-04-03 2016-04-03 Szczepy bakteriofagów i ich zastosowania
US16/090,772 US11077155B2 (en) 2016-04-03 2017-04-03 Bacteriophage strains and their applications
CA3019820A CA3019820A1 (en) 2016-04-03 2017-04-03 Bacteriophage strains and their applications
MX2018012099A MX2018012099A (es) 2016-04-03 2017-04-03 Cepas de bacteriofagos y sus aplicaciones.
CN201780032927.5A CN109310721B (zh) 2016-04-03 2017-04-03 噬菌体菌株及其应用
PCT/PL2017/050018 WO2017176136A1 (en) 2016-04-03 2017-04-03 Bacteriophage strains and their applications
EP17779411.2A EP3439677A4 (en) 2016-04-03 2017-04-03 STRAINS OF BACTERIOPHAGES AND THEIR APPLICATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL416716A PL416716A1 (pl) 2016-04-03 2016-04-03 Szczepy bakteriofagów i ich zastosowania

Publications (1)

Publication Number Publication Date
PL416716A1 true PL416716A1 (pl) 2017-10-09

Family

ID=59996955

Family Applications (1)

Application Number Title Priority Date Filing Date
PL416716A PL416716A1 (pl) 2016-04-03 2016-04-03 Szczepy bakteriofagów i ich zastosowania

Country Status (7)

Country Link
US (1) US11077155B2 (pl)
EP (1) EP3439677A4 (pl)
CN (1) CN109310721B (pl)
CA (1) CA3019820A1 (pl)
MX (1) MX2018012099A (pl)
PL (1) PL416716A1 (pl)
WO (1) WO2017176136A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112391357A (zh) * 2019-08-14 2021-02-23 宁波大学 温和气单胞菌高效裂解性噬菌体vB_AsoP-yong及其应用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112280747B (zh) * 2019-07-22 2022-11-18 渤海大学 一种荧光假单胞菌的烈性噬菌体ΦPf1901、噬菌体ΦPf1901的制剂及其应用
CN110484513B (zh) * 2019-08-23 2021-04-16 中国水产科学研究院黑龙江水产研究所 噬菌体pAhMJG及其在治疗嗜水气单胞菌引发的鱼类疾病中的应用
CN112574959B (zh) * 2020-11-17 2022-05-24 厦门昶科生物工程有限公司 一种防治水产动物气单胞菌病害的噬菌体及微生态制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2335852A (en) * 1998-03-31 1999-10-06 Martin Smirthwaite The production, use and treatment using phage technology in aquaculture
US20050118567A1 (en) * 2002-01-23 2005-06-02 Merril Carl R. Method for determining sensitivity to a bacteriophage
GB0808780D0 (en) * 2008-05-15 2008-06-18 Big Dna Ltd Fish vaccines
US9504721B2 (en) * 2012-06-04 2016-11-29 Ctc Bio, Inc. Bacteriophage and its use for preventing proliferation of pathogenic bacteria
CL2012002902A1 (es) * 2012-10-17 2013-05-03 Univ Chile Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas.
CN104450629A (zh) * 2014-09-28 2015-03-25 浙江省淡水水产研究所 一株中华鳖气单胞菌噬菌体及其应用
BR112017022463B1 (pt) * 2015-04-20 2021-10-13 Fixed Phage Limited Composição, rações para crustáceos ou peixes e métodos de fabricação das mesmas

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112391357A (zh) * 2019-08-14 2021-02-23 宁波大学 温和气单胞菌高效裂解性噬菌体vB_AsoP-yong及其应用

Also Published As

Publication number Publication date
WO2017176136A1 (en) 2017-10-12
US11077155B2 (en) 2021-08-03
EP3439677A1 (en) 2019-02-13
CN109310721B (zh) 2022-02-18
CN109310721A (zh) 2019-02-05
US20200323931A1 (en) 2020-10-15
MX2018012099A (es) 2019-06-24
EP3439677A4 (en) 2019-08-28
CA3019820A1 (en) 2017-10-12

Similar Documents

Publication Publication Date Title
PL416716A1 (pl) Szczepy bakteriofagów i ich zastosowania
MX2020012602A (es) Composiciones bacterianas dise?adas y usos de las mismas.
BR112013027609A2 (pt) bactérias bacillus para uso no tratamento e prevenção de infecção em animais aquáticos
PH12017500708A1 (en) Probiotic and prebiotic compositions
BR112013005426A2 (pt) "composto, composição, formulação farmacêutica, métodos para inibir uma enzima, para matar e/ou prevenir o crescimento de um micro-organismo, para tratar e/ou prevenir uma doença em um animal, e para inibir o domínio de edição de uma sintetase de t-rna, e, uso de um composto ou uma de combinação."
Kuenzli Antibiotic resistance and international travel: Causes and consequences
HRP20191363T1 (hr) Terapija bakteriofagima
NZ706636A (en) Probiotic and prebiotic compositions
RU2015105738A (ru) Непатогенный штамм f18 е. coli и его применение
ZA202002093B (en) Antibacterial compounds
UA112551C2 (uk) Штам бактеріофага та його застосування
MX2019006768A (es) Peptidos antimicrobianos.
EA201890412A1 (ru) АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ
Syarif et al. Potensi ekstrak etanol 70% akar saluang balum (Lavanga sarmentosa blume kurz) terhadap kualitas dan viabilitas sperma mencit
Moore et al. An oxytetracycline bath protocol to eliminate the agent of withering syndrome, Candidatus Xenohaliotis californiensis, in captive abalone populations
PH12017502432A1 (en) Compositions and methods for using lamellar bodies for therapeutic purposes
ZA202006986B (en) Dantrolene formulations and methods of their use
WO2016072854A3 (en) Pantothenamide analogues
Mirghaed et al. Corrigendum to'The effects singular or combined administration of fermentable fiber and probiotic on mucosal immune parameters, digestive enzyme activity, gut microbiota and growth performance of Caspian white fish (Rutilus frisii kutum) fingerlings'[Fish and Shellfish Immunol. 77 (2018) 194-199]
UA119652U (uk) ШТАМ БАКТЕРІЙ Pseudomonas aureofaciens - ІМВ В-7559, ДЛЯ ВИКОРИСТАННЯ ЯК САМОСТІЙНОГО ДІЮЧОГО АГЕНТА, ТАК І В СКЛАДІ РІЗНОМАНІТНИХ КОНСОРЦІУМІВ МІКРООРГАНІЗМІВ ПРИ ОТРИМАННІ БІОПРЕПАРАТІВ ДЛЯ ЗАХИСТУ РОСЛИН З АНТИМІКРОБНОЮ, ФУНГІЦИДНОЮ, ЕНТОМОПАТОГЕНОЮ ТА РІСТСТИМУЛЮЮЧОЮ ДІЄЮ.
PL413052A1 (pl) Szczep bakteriofagowy oraz jego zastosowanie do leczenia infekcji powodowanych przez bakterie Proteus mirabilis zwłaszcza przez szczepy lekooporne
TH1801001520A (th) สารต้านจุลินทรีย์และวิธีการสำหรับการระงับโรคที่เกิดขึ้นมาโดยการติดเชื้อVibrioparahaemolyticusของสิ่งมีชีวิตในน้ำ
PL418826A1 (pl) Zastosowanie bakteriofagów w kompozycji ze środkami antybakteryjnymi do zwalczania leko- i wielolekoopornych szczepów Proteus mirabilis
Ozaraga et al. Ethnobotanical Anthelmintics for Free Range Native Chickens
PL416205A1 (pl) Nowe szczepy bakterii probiotycznych do zwalczania Escherichia coli i Clostridium perfringens u ptaków hodowlanych, zwłaszcza u drobiu kompozycje szczepów bakterii probiotycznych i ich zastosowania